CompletedPhase 2NCT02275351

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Biosplice Therapeutics, Inc.
Principal Investigator
Yusuf Yazici, M.D., MD
Biosplice Therapeutics, Inc.
Intervention
SM04554(drug)
Enrollment
310 enrolled
Eligibility
18-55 years · MALE
Timeline
20142015

Study locations (23)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02275351 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials